from generic co Lannett today ---$86 bil new generics coming "According to Lannett, $86 billion of brand drugs are coming off patent through 2017. Baby boomers should be a strong growth driver for the drug industry in the following years. The generics industry is on a secular growth path and Lannett will certainly benefit from those trends. Lannett currently has 39 marketed products, 43 products in development and 20 products pending approval. The 20 products that are pending approval had 2013 sales (branded and generic) around $2.8 billion. If Lannett captures just a couple of percentage points of the addressable market, the potential revenues from these products could exceed $100 million in the next couple of years.
The most important market for Lannett in the following years should be the controlled substance market. The controlled substance market in the U.S. had $26 billion in sales in 2013 with the generic portion contributing $9.7 billion. This market has a high barrier to entry as it is controlled by the DEA."